BioPharmX Corp. (BPMX)

0.12
0.01 14.01
AMEX : Producer Manufacturing
Prev Close 0.10
Open 0.11
Day Low/High 0.10 / 0.12
52 Wk Low/High 0.05 / 0.38
Volume 11.31M
Avg Volume 4.23M
Exchange AMEX
Shares Outstanding 218.31M
Market Cap 22.20M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

BioPharmX Completes Enrollment In Phase 2b Trial Of BPX-04 For Patients With Papulopustular Rosacea

BioPharmX Completes Enrollment In Phase 2b Trial Of BPX-04 For Patients With Papulopustular Rosacea

Company anticipates announcing topline efficacy and safety results in July 2019

BioPharmX Strengthens Board Of Directors With Appointment Of Industry Veteran Dr. R. Todd Plott

BioPharmX Strengthens Board Of Directors With Appointment Of Industry Veteran Dr. R. Todd Plott

Dr. R. Todd Plott, developer of SOLODYN™, ZIANA™, and NORITATE™, becomes company's third independent director

BioPharmX Receives Notice Of Noncompliance From NYSE American

BioPharmX Receives Notice Of Noncompliance From NYSE American

MENLO PARK, Calif., Dec.

BioPharmX Reports Third Quarter 2019 Financial Results

BioPharmX Reports Third Quarter 2019 Financial Results

MENLO PARK, Calif., Dec.

BioPharmX Initiates Phase 2b Trial Of BPX-04 For Rosacea

BioPharmX Initiates Phase 2b Trial Of BPX-04 For Rosacea

Trial will evaluate 1% concentration of minocycline carried by company's patented HyantX™ delivery system

BioPharmX Receives Notice Of Noncompliance From NYSE American

BioPharmX Receives Notice Of Noncompliance From NYSE American

MENLO PARK, Calif., Sept.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

5 Stocks Under $10 Poised for Big Breakouts

5 Stocks Under $10 Poised for Big Breakouts

These under-$10 stocks are within range of triggering breakout trades. Here's how to play them.

BioPharmX (BPMX) Stock Spikes on Acne Medication Trial Success

BioPharmX (BPMX) Stock Spikes on Acne Medication Trial Success

BioPharmX (BPMX) reported successful results from a safety study of its topical gel medication for acne, BPX-01, on Monday.

Trade These 5 Biotech Breakouts Now for Big Gains

Trade These 5 Biotech Breakouts Now for Big Gains

Here's a technical look at how to trade five biotech stocks that are setting up to break out and trade much higher.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: APEI, OI, ZPIN Downgrades: DFRG Initiations: BPMX, FTAI, KEN, NYLD, RKDA Read on to get TheStreet Quant Ratings' detailed report:

BioPharmX (BPMX) Stock Soars on Potential 'Breakthrough' Acne Treatment

BioPharmX (BPMX) Stock Soars on Potential 'Breakthrough' Acne Treatment

BioPharmX stock is rising on heavy trading volume on Monday after the pharmaceutical company said it may have developed a breakthrough treatment for acne.

TheStreet Quant Rating: D (Sell)